Pharmacoequity Conference

May 20, 2022 -
9:00am to 1:00pm

9:00 Keynote:

Jasmine Marcelin, MD (University of Nebraska); Q&A with Marcella Nunez-Smith, MD, MHS (Yale School of Medicine)

10:00 Panel:

Racial and Ethnic Disparities in Use of Medications for Opioid Use Disorder in Medicaid—Julie Donohue, PhD

Perceived Effectiveness of Medications for Depression by Race, Ethnicity and Place—Sirry Alang, PhD (Lehigh University)

Barriers to the Equitable Implementation of Essential Medicines for Oral Health—Jacqueline Burgette, DMD, PhD (University of Pittsburgh)

11:00 Panel:

Equity and the Allocation of Scarce Therapeutics During the COVID-19 Pandemic—Douglas White, MD, MAS (University of Pittsburgh)

Medicare Prescription Drug Coverage and Costs—Joseph Ross, MD, MHS (Yale School of Medicine)

Strategies to Advance Contraceptive Equity--Sonya Borrero, MD, MS (University of Pittsburgh)


with lunch

Closing remarks—Utibe R. Essien, MD, MPH (University of Pittsburgh)

Abstract: University of Pittsburgh cardiovascular health equity researcher Utibe R. Essien coined the term ‘pharmacoequity’ to “portray a health system where all patients, regardless of race, class, or availability of resources, have access to the highest quality, evidence-based medical therapy indicated for their condition.” This conference will explore what is necessary for pharmacoequity and what is being done, particularly at the University of Pittsburgh, to achieve it. Panels will include three Center for Bioethics & Health Law faculty: Julie Donohue, Doug White, and Sonya Borrero.


Sponsored by the Center for Pharmaceutical Policy and Prescribing (CP3)

Location and Address

Online and University Club, Ballroom A